Concentrated exposure and response prevention for children with OCD
Official title: A Single Group Evaluation of Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder
Run by Uppsala University Hospital · NCT06621381 · Data updated 2026-11-12
This study is testing a new week-long treatment for children aged 6-12 with OCD to see if it helps reduce their symptoms and improve their daily lives.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 12 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Uppsala University Hospital Academic / other |
| Locations | 1 site (Uppsala, Region Uppsala) |
| Status | Recruiting |
| Started | September 11, 2024 |
| Main results expected | December 14, 2029 |
| Study ends | December 14, 2029 |
| Registry record updated | October 1, 2024 |
| Trial ID | NCT06621381 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 6-12 years diagnosed with obsessive-compulsive disorder whose guardians consent to the treatment.
✕Probably not a fit
Patients or guardians who cannot communicate in Swedish will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the preliminary outcomes of a concentrated exposure and response prevention approach for children aged 6-12 years with obsessive-compulsive disorder (OCD). Conducted at Uppsala University Hospital, the study involves trained therapists delivering treatment in an outpatient setting. Participants will receive psychoeducation in a group format followed by individual exposure and response prevention sessions concentrated over one week. The study aims to assess treatment effects on OCD symptoms, functional impact, family accommodation, and clinician ratings of severity and improvement.
Why it matters
Potential benefit: If successful, this approach could significantly reduce OCD symptoms in children and improve their overall functioning.
How similar studies have gone: Other studies have shown success with exposure and response prevention techniques in treating OCD, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient fulfills the diagnostic criteria of obsessive-compulsive disorder * The patient and the legal guardians have said yes to receiving the concentrated exposure with response prevention - treatment Exclusion Criteria: * The patient/legal guardians are unable to communicate in Swedish
Where it's running
-
Uppsala University Hospital
Uppsala, Region Uppsala, Sweden Recruiting
Study contacts
- Principal investigator: Vendela Zetterqvist, Ph D, Associate Professor — Uppsala University Hospital
- Study coordinator: Vendela Zetterqvist, Ph D, Associate professor
- Email: vendela.zetterqvist@uu.se
- Phone: +46 (0)768107060
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-intensity focused ultrasound targeting the subthalamic nucleus for OCD
A short test is being done to see if a wearable, non-invasive ultrasound device can safely and tolerably help adults with OCD by targeting a brain region called the subthalamic nucleus.
-
Mindfulness-Based Cognitive Therapy for OCD Delivered Online
This study tests a synchronous online MBCT program for adults with OCD to see if it is acceptable and feasible and to explore links between biological markers, OCD severity, and treatment response.
-
Targeted brain stimulation for OCD: test of tTIS on nucleus accumbens
This study tests whether targeted temporal interference stimulation of the nucleus accumbens can help reduce obsessive-compulsive symptoms in adults with OCD, compared with sham stimulation.
-
Anxiety Skills Study: See if video skill training plus therapy helps people with anxiety
This study tests whether a brief video-based skill training can help people with anxiety as well as four therapy sessions, and how durable the effects are over a year.
-
AttunE LIFU for OCD: a non-invasive brain stimulation study
This trial tests ATTN201, a wearable ultrasound headband, to see if it helps adults with OCD compared to a sham treatment.
-
Combined ERP and Habit Reversal Therapy for Tourettic OCD
This study tests whether a merged Exposure and Response Prevention and Habit Reversal Therapy helps adults with Tourettic OCD more than either therapy alone or basic psychoeducation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.